다안 암 연구실은 임상과 연계된 국내 최고의 중개 연구실이며, 국내외 제약사와의 공동연구를 통해 표적치료제, 면역항암제 등 치료 전략을 연구하고 있습니다.
Investors 1
Mentions in press and media 1
| Date | Title | Description |
| 14.07.2022 | GenScript ProBio and DAAN Bio Therapeutics, Sign a Strategic Cooperation MOU for the Discovery and Development of Novel Drugs | SEOUL, South Korea, July 14, 2022 /PRNewswire/ -- On the July 14, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and DAAN Bio Therapeutics (Byoung Chul Cho, Co-Founder & CEO), an innovative new drug developer such as an... |
Reviews 0
